Advertisement
Research Article

Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity

  • Jordi Riba,

    Affiliations: Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany, Departament de Farmacologia i Terapéutica, Centre d'Investigació del Medicament, Institut de Recerca, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain

    X
  • Ulrike M. Krämer,

    Affiliation: Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany

    X
  • Marcus Heldmann,

    Affiliations: Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany, Department of Neurology II, University of Magdeburg, Magdeburg, Germany

    X
  • Sylvia Richter,

    Affiliations: Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany, Department of Neurochemistry and Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany

    X
  • Thomas F. Münte mail

    Thomas.muente@med.uni-magdeburg.de

    Affiliations: Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany, Center for Behavioral Brain Sciences, Magdeburg, Germany

    X
  • Published: June 25, 2008
  • DOI: 10.1371/journal.pone.0002479

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.